Commercial coverage
Does Blue Cross Blue Shield of Illinois cover Rybelsus?
Rybelsus (semaglutide (oral)) for type 2 diabetes — the Blue Cross Blue Shield of Illinois prior-authorization rule, source-cited.
Blue Cross Blue Shield of Illinois Rybelsus PA criteria
Covers Ozempic & Rybelsus, Mounjaro, Trulicity, Victoza & generic liraglutide, Byetta/exenatide, Bydureon BCise (PA with Quantity Limit via Prime Therapeutics).
Requires diagnosis of T2DM confirmed by ONE of A1C >=6.5%, FPG >=126, 2-hr OGTT PG >=200, or random PG >=200 with hyperglycemia symptoms.
Step therapy is WITHIN the GLP-1 class (not metformin).
PREFERRED: Bydureon BCise, Mounjaro, Ozempic, Rybelsus, Trulicity.
NON-PREFERRED: Byetta, generic Exenatide, Victoza/liraglutide.
A non-preferred agent is approved only when the patient satisfies TWO of three modules (tried-inadequate OR intolerance/contraindication to semaglutide, dulaglutide, and/or tirzepatide) - TWO of three, not all three.
Not combined with another GLP-1 or a DPP-4 inhibitor; age within FDA labeling.
BCBSIL FI/ASO-Cost/HIM/non-ERISA ASO members and patients already stable on the agent bypass the step.
Approval 12 months (initial and renewal).
Source: HCSC/Prime GLP-1 Agonists PAQL Program Summary (eff. 05-11-2026) & Weight Management PA Fax Form 7319 HCSC WEMT 0526 (rev. May 2026). View cited GLP-1 policy reference →
Frequently asked
- Does Blue Cross Blue Shield of Illinois cover Rybelsus for type 2 diabetes?
- Covered with prior authorization. Covers Ozempic & Rybelsus, Mounjaro, Trulicity, Victoza & generic liraglutide, Byetta/exenatide, Bydureon BCise (PA with Quantity Limit via Prime Therapeutics). See the full source-cited criteria above. Per HCSC/Prime GLP-1 Agonists PAQL Program Summary (eff. 05-11-2026) & Weight Management PA Fax Form 7319 HCSC WEMT 0526 (rev. May 2026), as of 2026 (diabetes ProgSum eff. 05-11-2026; WM fax form rev. May 2026; accessed 2026-06-15) — confirm the member's current plan policy.
d3rx does not hold plan-specific pharmacy formularies or PBM prior-auth grids, so it cannot confirm a particular plan's GLP-1 coverage, tier, or PA criteria. The guidance below is the general, source-cited rule; confirm the specific plan's pharmacy formulary / PA policy for a binding answer.
Check Rybelsus for another payer — or draft the PA
Run Rybelsus + any payer in the GLP-1 PA lookup, or have Ask D3 draft a Blue Cross Blue Shield of Illinois-ready prior-authorization request with the right criteria and codes — free, no signup.